Embody vs CoreAge Rx: $299 regular vs $79 prepaid
Checked 17 October 2026, Embody's one-month semaglutide page labels a $79 sale price and a $299 regular price, and the tirzepatide page labels a $129 sale price and a $349 regular price.
Neither page publishes a selling plan, and the sale price is not the continuing price.
Rankings use the regular price.
Checked 7 October 2026, CoreAge Rx lists compounded semaglutide at $79 a month, paying $948 for 12 months up front, and compounded tirzepatide at $129 a month, paying $1,548 for 12 months up front.
CoreAge Rx does not record a separate month-to-month charge for those two programs.
The matching dollar amounts are not the same billing basis.
We may earn a commission if you start a program through links on this page. It doesn't change prices or how we sort them. Disclosure

Embody
- Ranked offers
- 2
- Lowest ranked offer
- $299/mo

CoreAge Rx
- Ranked offers
- 5
- Lowest ranked offer
- $79/mo
Same program, recorded price
Each cell is that provider’s recorded price for the program, with the billing basis and the date it was checked. A matching dollar figure can still be a different plan.
| Program | Embody | CoreAge Rx |
|---|---|---|
| Compounded semaglutide injectioncompounded (not FDA-approved) | Compounded semaglutide injection: $299 regular price; one-month sale $79. Checked 21 October 2026.compounded (not FDA-approved) | Compounded semaglutide injection: $79 a month, paying $948 for 12 months up front. Checked 22 October 2026.compounded (not FDA-approved) |
| Compounded tirzepatide injectioncompounded (not FDA-approved) | Compounded tirzepatide injection: $349 regular price; one-month sale $129. Checked 21 October 2026.compounded (not FDA-approved) | Compounded tirzepatide injection: $129 a month, paying $1,548 for 12 months up front. Checked 22 October 2026.compounded (not FDA-approved) |
Published prices on record
Each figure is the provider’s recorded price, with the page it was read from and the date it was checked. A starting price is not the same billing basis as a continuing monthly price.
Embody
| Program | Price | Checked | Source |
|---|---|---|---|
| Compounded semaglutide injectionCompounded semaglutide injection | $299 regular price; one-month sale $79 | 21 October 2026 | Source |
| Compounded tirzepatide injectionCompounded tirzepatide injection | $349 regular price; one-month sale $129 | 21 October 2026 | Source |
| Rodeo ED treatmentClinician-selected compounded oral doses | $99 / 6 doses or $119 / 12 doses | 22 August 2026 | Source |
CoreAge Rx
| Program | Price | Checked | Source |
|---|---|---|---|
| Compounded semaglutide injectionCompounded semaglutide injection | $79 a month, paying $948 for 12 months up front | 22 October 2026 | Source |
| Compounded tirzepatide injectionCompounded tirzepatide injection | $129 a month, paying $1,548 for 12 months up front | 22 October 2026 | Source |
| NAD+ injectableCompounded NAD+ injection | $93 a month, continuing | 22 October 2026 | Source |
| NAD+ nasal sprayCompounded NAD+ nasal spray | $93 a month, continuing | 22 October 2026 | Source |
| Overnight Rebound sermorelinCompounded Sermorelin injection | $99 a month, continuing | 20 October 2026 | Source |
Programs both providers publish
Related pages
Common questions
- Do Embody and CoreAge Rx both list $79 compounded semaglutide and $129 compounded tirzepatide?
- Those amounts appear on both, on different bases. Checked 17 October 2026, Embody labels $79 and $129 as one-month sale prices, against regular prices of $299 and $349. Checked 7 October 2026, CoreAge Rx lists $79 and $129 as the monthly equivalent of 12-month plans paid in full, $948 and $1,548.
- Is Embody's $79 the same kind of price as CoreAge Rx's $79?
- No. Embody's $79 is the one-month sale price checked 17 October 2026, and the ranking figure is the $299 regular price. CoreAge Rx's $79 is the monthly equivalent of a 12-month plan paid in full, checked 7 October 2026. Neither figure is recorded as a calendar-month continuing price.
- Is this the cheapest compounded GLP-1 on the market?
- No. These rows are commission-earning providers tracked here, and the dollar amounts are not the same billing basis. The sale price, the regular price, and the prepaid effective rate stay separate on the cheapest semaglutide and cheapest tirzepatide pages.
- Does either provider publish an oral semaglutide price?
- No oral semaglutide or oral tirzepatide price is recorded for Embody or CoreAge Rx. CoreAge Rx does publish NAD+ injection at $93 a month, continuing, NAD+ nasal spray at $93 a month, continuing, and sermorelin injection at $99 a month, continuing, checked 7 October 2026. No NAD+ or sermorelin price is recorded for Embody.
Sources and limits
Prices and terms can change. Confirm the current programme, eligibility, and total cost with the provider.
- CoreAge Rx annual prepaid pricing: corrected card identity Checked 7 October 2026. Semaglutide is $79/month equivalent ($948 for 12 months); tirzepatide is $129/month equivalent ($1,548 for 12 months). The footer bases advertised starting prices on a 12-month plan paid in full. The absolute-positioned price elements are not in visual order in the HTML: text-773 ($79) belongs to the semaglutide card/button-771; text-775 ($129) belongs to the tirzepatide card/button-774. These are annual prepaid equivalents, not month-to-month charges. The main product pages retain different $99/$149 starting figures; the source and plan scope are the home35 offer.